TwycrossR, WilcockA, CharlesworthS, et al.: Palliativedrugs.com therapeutic highlights: Gabapentin. Indian J Palliat Care, 2003; 9:71–74.
2.
BockbraderHN, WescheD, MillerR, et al.: A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin. Clin Pharmacokinet, 2010; 49:661–669.
FarrarJT, PortenoyRK: Neuropathic cancer pain: The role of adjuvant analgesics. Oncology (Williston Park), 2001; 15:1435–1442,1445; discussion 1445,1450–1453.
6.
PaseroC, McCafferyM: Pain Assessment and Pharmacological Management, 1st ed. St. Louis, MO: Mosby, 1991.
7.
BrilV, EnglandJ, FranklinGM, et al.; American Academy of Neurology; American Association of Neuromuscular and Electrodiagnostic Medicine; American Academy of Physical Medicine and Rehabilitation: Evidence-based guideline: Treatment of painful diabetic neuropathy: Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology, 2011; 76:1758–1765.
8.
MishraS, BhatnagarS, GoyalGN, et al.: A comparative efficacy of amitriptyline, gabapentin, and pregabalin in neuropathic cancer pain: A prospective randomized double-blind placebo-controlled study. Am J Hosp Palliat Care, 2012; 29:177–182.
